Pesquisas alternativas:
elderly completed » elderly complete (Expandir a Pesquisa), elderly complicated (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
completed phase » completely phased (Expandir a Pesquisa), incomplete phase (Expandir a Pesquisa), complex phase (Expandir a Pesquisa)
nasal comer » nasal com (Expandir a Pesquisa), nasal como (Expandir a Pesquisa), nasal complex (Expandir a Pesquisa)
comas con » compras con (Expandir a Pesquisa), formas con (Expandir a Pesquisa), poemas con (Expandir a Pesquisa)
a elderly » can elderly (Expandir a Pesquisa), care elderly (Expandir a Pesquisa)
comer dan » romer dan (Expandir a Pesquisa), comer diane (Expandir a Pesquisa), comer vann (Expandir a Pesquisa)
con neto » con feto (Expandir a Pesquisa), con veto (Expandir a Pesquisa), con net (Expandir a Pesquisa)
m comas » m comps (Expandir a Pesquisa), m cobas (Expandir a Pesquisa)
3 nasal » bi nasal (Expandir a Pesquisa), cf nasal (Expandir a Pesquisa), 3 nataly (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
elderly completed » elderly complete (Expandir a Pesquisa), elderly complicated (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
completed phase » completely phased (Expandir a Pesquisa), incomplete phase (Expandir a Pesquisa), complex phase (Expandir a Pesquisa)
nasal comer » nasal com (Expandir a Pesquisa), nasal como (Expandir a Pesquisa), nasal complex (Expandir a Pesquisa)
comas con » compras con (Expandir a Pesquisa), formas con (Expandir a Pesquisa), poemas con (Expandir a Pesquisa)
a elderly » can elderly (Expandir a Pesquisa), care elderly (Expandir a Pesquisa)
comer dan » romer dan (Expandir a Pesquisa), comer diane (Expandir a Pesquisa), comer vann (Expandir a Pesquisa)
con neto » con feto (Expandir a Pesquisa), con veto (Expandir a Pesquisa), con net (Expandir a Pesquisa)
m comas » m comps (Expandir a Pesquisa), m cobas (Expandir a Pesquisa)
3 nasal » bi nasal (Expandir a Pesquisa), cf nasal (Expandir a Pesquisa), 3 nataly (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
1
Por Barnadas, A, Gil, M, González, S, Tusquets, I, Muñoz, M, Arcusa, A, Prieto, L, Margelí-Vila, M, Moreno, A
Publicado em 2009
“... complete response was observed in breast and axilla in one patient (2.3%) and different forms of persistent...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Santini, V, Allione, B, Zini, G, Gioia, D, Lunghi, M, Poloni, A, Cilloni, D, Sanna, A, Masiera, E, Ceccarelli, M, Abdel-Wahab, O, Terenzi, A, Angelucci, E, Finelli, C, Onida, F, Pelizzari, A, Ferrero, D, Saglio, G, Figueroa, M, Levis, A
Publicado no Leukemia (2018)
“..., CMML patients received intravenous decitabine 20 mg/m(2) per day on Days 1–5 of a 28-day treatment...”Publicado no Leukemia (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Cooper, BW, Kindwall-Keller, TL, Craig, MD, Creger, RJ, Hamadani, M, Tse, WW, Lazarus, HM
Publicado no Clin Lymphoma Myeloma Leuk (2015)
“...BACKGROUND: Midostaurin is a novel, orally available FLT3 tyrosine kinase inhibitor that induces...”Publicado no Clin Lymphoma Myeloma Leuk (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Kopecky, Ernest A., Vaughn, Ben, Lagasse, Scott, O’Connor, Melinda
Publicado no Drugs Aging (2017)
“...TRIAL DESIGN: This was a phase III, randomized withdrawal, double-blind, placebo-controlled...”Publicado no Drugs Aging (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Ocio, Enrique M., Herrera, Pilar, Olave, María-Teresa, Castro, Nerea, Pérez-Simón, José A., Brunet, Salut, Oriol, Albert, Mateo, Marta, Sanz, Miguel-Ángel, López, Javier, Montesinos, Pau, Chillón, María-Carmen, Prieto-Conde, María-Isabel, Díez-Campelo, María, González, Marcos, Vidriales, María-Belén, Mateos, María-Victoria, San Miguel, Jesús F.
Publicado no Haematologica (2015)
“... with idarubicin (8 mg/m(2) iv days 1–3) plus cytarabine (100 mg/m(2) iv days 1–7) plus panobinostat po...”Publicado no Haematologica (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Attia, Steven, Traynor, Anne M., Kim, KyungMann, Merchant, Joseph J., Hoang, Tien, Ahuja, Harish G., Beatty, Peter A., Hansen, Richard M., Masters, Gregory A., Oettel, Kurt R., Shapiro, Gary R., Larson, Martha M., Larson, Marilyn L., Schiller, Joan H.
Publicado em 2008
“...) of oral exisulind with 25 mg/m(2)/week of intravenous (IV) vinorelbine on a 28-day cycle. Patients...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Baxter, Ruth, Taylor, Natalie, Kellar, Ian, Pye, Victoria, Mohammed, Mohammed A, Lawton, Rebecca
Publicado no BMJ Open (2018)
“..., broad measure of patient safety. DESIGN: A two-phased observational study was conducted. During phase 1...”Publicado no BMJ Open (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Camerini, Andrea, Puccetti, Cheti, Donati, Sara, Valsuani, Chiara, Petrella, Maria Cristina, Tartarelli, Gianna, Puccinelli, Paolo, Amoroso, Domenico
Publicado no BMC Cancer (2015)
“...BACKGROUND: Metronomic oral vinorelbine could be a safe option for elderly patients with advanced...”Publicado no BMC Cancer (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ohba, Akihiro, Kato, Ken, Ito, Yoshinori, Katada, Chikatoshi, Ishiyama, Hiromichi, Yamamoto, Sachiko, Ura, Takashi, Kodaira, Takeshi, Kudo, Shigehiro, Tamaki, Yoshio
Publicado no Adv Radiat Oncol (2016)
“... of chemoradiation therapy (CRT) with docetaxel (DTX) in elderly patients with stage II/III (non-T4) esophageal...”Publicado no Adv Radiat Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Nakao, Akira, Hiranuma, Osamu, Uchino, Junji, Sakaguchi, Chikara, Kita, Toshiyuki, Hiraoka, Noriya, Ishizuka, Tamotsu, Kubota, Yutaka, Kawasaki, Masayuki, Goto, Yasuhiro, Imai, Hisao, Hattori, Noboru, Nakatomi, Keita, Uramoto, Hidetaka, Uryu, Kiyoaki, Fukuda, Minoru, Uchida, Yasuki, Yokoyama, Toshihide, Akai, Masaya, Mio, Tadashi, Nagashima, Seiji, Chihara, Yusuke, Tamiya, Nobuyo, Kaneko, Yoshiko, Mouri, Takako, Yamada, Tadaaki, Yoshimura, Kenichi, Fujita, Masaki, Takayama, Koichi
Publicado no Oncologist (2019)
“...LESSONS LEARNED. Non‐small‐cell lung cancer (NSCLC) represents 85% of lung cancer in elderly...”Publicado no Oncologist (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko
Publicado em 2020-02-01
“... who participated in a multicenter, non-randomized clinical trial of phase II ERIVANCE BBC...”Publicado em 2020-02-01
Obter o texto integral
Artigo
12
Por Storti, Sergio, Spina, Michele, Pesce, Emanuela Anna, Salvi, Flavia, Merli, Michele, Ruffini, Alessia, Cabras, Giuseppina, Chiappella, Annalisa, Angelucci, Emanuele, Fabbri, Alberto, Liberati, Anna Marina, Tani, Monica, Musuraca, Gerardo, Molinari, Annalia, Petrilli, Maria Pia, Palladino, Carmela, Ciancia, Rosanna, Ferrario, Andrea, Gasbarrino, Cristiana, Monaco, Federico, Fraticelli, Vincenzo, De Vellis, Annalisa, Merli, Francesco, Luminari, Stefano
Publicado no Haematologica (2018)
“...We conducted a phase II study to assess activity and safety profile of bendamustine and rituximab...”Publicado no Haematologica (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Munoz-Bendix, Christopher, Rapp, Marion, Mijderwijk, Hendrik-Jan, von Sass, Christiane, Dibué-Adjei, Maxine, Cornelius, Jan Frederick, Steiger, Hans-Jakob, Turowski, Bernd, Sabel, Michael, Kamp, Marcel A.
Publicado no Sci Rep (2019)
“... cohort do not seem to differ from recent phase III studies with non-geriatric patients. Nevertheless...”Publicado no Sci Rep (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kater, Arnon P., van Oers, Marinus H.J., van Norden, Yvette, van der Straten, Lina, Driessen, Julia, Posthuma, Ward F.M., Schipperus, Martin, Chamuleau, Martine E.D., Nijland, Marcel, Doorduijn, Jeanette K., Van Gelder, Michel, Hoogendoorn, Mels, De Croon, Francien, Wittebol, Shulamiet, Kerst, J. Martijn, Marijt, Erik W.A., Raymakers, Reinier A.P., Schaafsma, Martijn R., Dobber, Johan A., Kersting, Sabina, Levin, Mark-David
Publicado no Haematologica (2019)
“... with this drug. We conducted a phase 1-2 study to evaluate the efficacy and safety of six cycles of chlorambucil...”Publicado no Haematologica (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Neumaier, Christian, Elena, Sperk, Grit, Welzel, Yasser, Abo-Madyan, Uta, Kraus-Tiefenbacher, Anke, Keller, Axel, Gerhardt, Marc, Sütterlin, Frederik, Wenz
Publicado em 2012
“... of radiotherapy of the tumor bed only in a selected group can be non-inferior to WBRT. METHODS/DESIGN...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Schliemann, Christoph, Gerss, Joachim, Wiebe, Stefanie, Mikesch, Jan-Henrik, Knoblauch, Nicola, Sauer, Tim, Angenendt, Linus, Kewitz, Tobias, Urban, Marc, Butterfass-Bahloul, Trude, Edemir, Sabine, Vehring, Kerstin, Müller-Tidow, Carsten, Berdel, Wolfgang E., Krug, Utz
Publicado no PLoS One (2016)
“...Nintedanib (BIBF 1120), a potent multikinase inhibitor of VEGFR-1/-2/-3, FGFR-1/-2/-3 and PDGFR-α...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Puts, Martine T E, Hsu, Tina, Mariano, Caroline, Monette, Johanne, Brennenstuhl, Sarah, Pitters, Eric, Ray, Jack, Wan-Chow-Wah, Doreen, Kozlowski, Natascha, Krzyzanowska, Monika, Amir, Eitan, Elser, Christine, Jang, Raymond, Prica, Anca, Krahn, Murray, Beland, Francois, Bergman, Simon, Koneru, Rama, Lemonde, Manon, Szumacher, Ewa, Zidulka, Joan, Fung, Shek, Li, Anson, Emmenegger, Urban, Mehta, Rajin, Flemming, Kendra, Breunis, Henriette, Alibhai, Shabbir M H
Publicado no BMJ Open (2019)
“... a pattern mixture model using an intent-to-treat approach (at 3, 6 and12 months). We will conduct a...”Publicado no BMJ Open (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Stinchcombe, Thomas E., Zhang, Ying, Vokes, Everett E., Schiller, Joan H., Bradley, Jeffrey D., Kelly, Karen, Curran, Walter J., Schild, Steven E., Movsas, Benjamin, Clamon, Gerald, Govindan, Ramaswamy, Blumenschein, George R., Socinski, Mark A., Ready, Neal E., Akerley, Wallace L., Cohen, Harvey J., Pang, Herbert H., Wang, Xiaofei
Publicado no J Clin Oncol (2017)
“... to 1.10 and HR, 1.00; 95% CI, 0.91 to 1.09, respectively). Elderly patients had a higher rate of grade ≥ 3...”Publicado no J Clin Oncol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Lionberger, Jack M., Pagel, John M., Sandhu, Vicky K., Xie, Hu, Shadman, Mazyar, Mawad, Raya, Boehm, Alexandra, Dean, Carol, Shannon-Dorcy, Kathleen, Scott, Bart L., Deeg, H. Joachim, Becker, Pamela S., Hendrie, Paul C., Walter, Roland B., Ostronoff, Fabiana, Appelbaum, Frederick R., Estey, Elihu H.
Publicado em 2014
“...), might provide a complete response (CR) rate ≥ 40% with <30% grade 3–4 non-haematological toxicity. We...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Reinink, Hendrik, de Jonge, Jeroen C, Bath, Philip M, van de Beek, Diederik, Berge, Eivind, Borregaard, Saskia, Ciccone, Alfonso, Csiba, Laszlo, Demotes, Jacques, Dippel, Diederik W, Kõrv, Janika, Kurkowska-Jastrzebska, Iwona, Lees, Kennedy R, Macleod, Malcolm R, Ntaios, George, Randall, Gary, Thomalla, Götz, van der Worp, H Bart
Publicado no Eur Stroke J (2018)
“... outcome at 90 days in elderly patients with acute stroke. DESIGN: International, 3 × 2-factorial...”Publicado no Eur Stroke J (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo